Lyon, France

Haematological malignancies

The course teaches to design treatment strategies and apply modern principles of target volume definition, fractionation and treatment techniques for radiation therapy in the multimodality treatment of haematological malignancies.

Radiation oncologists involved in the treatment of haematological malignancies.

Course Director

Lena Specht, Clinical Oncologist, Rigshospitalet, University of Copenhagen, Denmark


Co-Course Director

Joachim Yahalom, Radiation Oncologist, Memorial Sloan-Kettering Cancer Center, New York, USA



George Mikhaeel, Clinical Oncologist, Guy’s Hospitalet and King’s College, London, UK

Tim Illidge, Clinical Oncologist, Christie Hospital, Manchester University, UK

Umberto Ricardi, Radiation Oncologist, University of Torino, Italy

Andrea Ng, Radiation Oncologist, Dana Farber and Brigham and Women’s Hospital, Harvard Medical School, Boston, US

Bouthaina Dabaja, Radiation Oncologist, MD Anderson Cancer Center, Houston, US

Brandon Imber, Radiation Oncologist, Memorial Sloan-Kettering Cancer Center, New York, USA

Anne Kiil Berthelsen, Radiologist, Rigshospitalet, University of Copenhagen, Denmark

Peter Borchmann, Medical Oncologist, University of Cologne, Germany

Andrew Davies, Medical Oncologist, University of Southampton, UK


Guest Lecturer

Gilles Salles, Haematologist, Memorial Sloan-Kettering Cancer Center, New York, USA, and University of Lyon, France


The aim of this course is to:

  • Enable radiation oncologists to participate in the modern multidisciplinary management of haematological malignancies
  • Administer radiotherapy to these diseases according to modern principles, using up-todate technology to achieve maximum cure rates while at the same time minimising the risk of long-term complications.

Learning Outcomes

By the end of this course participants should be able to:

  • Design strategies for the multimodality treatment of haematological malignancies
  • Apply modern principles for radiotherapy in the multimodality setting
  • Define target volumes and prescribe radiation doses and fractionation schedules appropriate for different haematological malignancies
  • Apply and evaluate different treatment techniques depending on disease localisations and risks of normal tissue complications.

Course Content

  • Role of radiation oncology in the multimodality treatment of lymphomas
  • General principles of treatment: radiotherapy (incl. protons for lymphomas), chemotherapy, immunotherapy (incl. CAR T-cell therapy), radioimmunotherapy, combined modality treatment and long term toxicity
  • Imaging for radiotherapy
  • Hodgkin lymphoma: classic and lymphocyte predominance; early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
  • Indolent nodal non-Hodgkin lymphoma: early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
  • Aggressive nodal non-Hodgkin lymphoma: early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
  • Extranodal lymphomas: characteristics, role of radiotherapy, volumes, doses and techniques
  • Other indications for radiotherapy: myeloma, granulocytic sarcoma, hypersplenism, total body irradiation as conditioning for transplant: volumes, doses and techniques.


Before commencing this course participants should:

  • Be a radiation oncologist with some experience
  • Have an interest in and knowledge of the spectrum of haematological malignancies
  • Read the publications mentioned below
  • Have completed the exercise on the two contouring cases sent out in advance.

Teaching Methods

  • 17 hours of lectures
  • 3 hours of practical workshops
  • 5 hours of case discussions.

State-of-the-art radiotherapy in the treatment of haematological malignancies will be discussed. The format of the course will be a combination of lectures and case discussions. A delineation session will be included, for which the participants will be expected to have done some homework in advance.

Methods of Assessment

  • Delineation exercise
  • Evaluation form.



Scientific Programme

Draft programme here


Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

Radisson Blu Hotel Lyon

129 Rue Servient

Lyon 69003



ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2023 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.



Early rate

Late rate


  750 EUR

 850 EUR

ESTRO Members

  600 EUR 

 725 EUR

In-training members*

  450 EUR

 625 EUR

* Members with specialty RadiationTherapist (RTT) may register at the In-Training fee

Early rates are applied up to 3 months before the starting date of the course.

Late rates are applied 3 months before the starting date of the course.

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

Since the number of participants is limited, late registrants are advised to contact the ESTRO office before payment, to inquire about availability of places. Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

ESTRO does not accept liability for individual medical, travel or personal accidents or incidents. Participants are strongly advised to take out their own personal insurance policies.   

For any cancellation made by the course or workshop participant, ESTRO School Events Cancellation Policy will be followed and all stated penalty fees will be applied. 

In the unlikely event that ESTRO would need to cancel the event, ESTRO will reimburse the participants in full for the registration fee. ESTRO will not refund any travel and accommodation expenses.

Reduced fees

Members from emerging countries may register at a preferential rate of 350 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here.

Additionally, all specialties from the following countries can benefit from this preferential rate: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Poland, Portugal, Romania, Russian Federation, Serbia, Slovak Republic, Slovenia, Spain, Turkey, Ukraine.  In addition, medical physicists from Cyprus can email to apply for this fee.

The preferential rate of 350 Euro is granted automatically when you click on the  BOOK NOW  button and the three conditions below are met:

  1. Only ESTRO members for 2023 are eligible (please make sure your 2023 membership is in order before you click on the BOOK NOW  button)
  2. Only one course per person per year can be subsidized by ESTRO
  3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

 Please note:

  • We can only guarantee a certain number of reduced fees per course
  • Application deadlines are the same as early registration fees